Silo Pharma Plunges 10.94% on Bitcoin Reserve Move

On June 6, 2025, Silo Pharma's stock experienced a significant drop of 10.94% in pre-market trading, marking a notable shift in investor sentiment.

Silo Pharma's recent strategic move to allocate up to $1 million in Bitcoin as a treasury reserve asset has been a focal point for investors. This decision, aimed at hedging against inflation and diversifying the company's asset portfolio, has garnered mixed reactions. While some investors view this as a forward-thinking strategy to enhance long-term value, others remain cautious about the volatility associated with cryptocurrencies.

Eric Weisblum, CEO of Silo Pharma, has emphasized that the acquisition of Bitcoin is part of a broader strategy to protect the company's financial health in an inflationary environment. This move has resonated with some investors, leading to fluctuations in the stock price. However, the recent pre-market drop suggests that there may be lingering concerns about the risks involved in holding Bitcoin as a treasury asset.